Aclaris Therapeutics (ACRS) Reports Q2 Loss of $0.62/Share
Aclaris Therapeutics (NASDAQ: ACRS) reported Q2 EPS of ($0.62), versus ($1.52) reported last year.
For earnings history and earnings-related data on Aclaris Therapeutics (ACRS) click here.
Aclaris Therapeutics (NASDAQ: ACRS) reported Q2 EPS of ($0.62), versus ($1.52) reported last year.
For earnings history and earnings-related data on Aclaris Therapeutics (ACRS) click here.